Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01974284 · ClinicalTrials.gov registry record · NA
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01974284 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 7 participants.
The verdict
NCT01974284, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.
Interventions
- DRUG percutaneous ethanol ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-03 |
| Est. Completion | 2017-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01974284
The ClinicalTrials.gov registry entry for NCT01974284 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which percutaneous ethanol ablation is the first listed.
NCT01974284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01974284 about?
NCT01974284 is a clinical study titled "Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma". We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.
What is the current status of trial NCT01974284?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2014-03. Estimated completion is 2017-06-29.
What interventions are being tested in trial NCT01974284?
The interventions under investigation include: percutaneous ethanol ablation (DRUG).
Who is sponsoring clinical trial NCT01974284?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.